[Alrheumum in the daily practice].

The new antirheumatic drug Ketoprofen (Alrheumun) has been tested by an open trial in 100 out-patients and the activity and tolerance have been evaluated under practice conditions. A daily dose of 3 capsules Alrheumun proved to have a good activity in patients with rheumatoid arthritis, osteoarthrosis and soft tissue conditions. 80% of all patients did not show to have any side-effects. Among all groups of patients, treatment had to be interupted because of side-effects in two patients only. A negative influence on any of the laboratory tests used was not found.